We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

205 hedge funds and large institutions have $1.17B invested in Coherus Oncology in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 25

17% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 66

5% more funds holding

Funds holding: 196 → 205 (+9)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

10.17% less ownership

Funds ownership: 120.54% → 110.37% (-10%)

22% less capital invested

Capital invested by funds: $1.51B → $1.17B (-$335M)

49% less call options, than puts

Call options by funds: $787K | Put options by funds: $1.54M

Holders
205
Holders Change
+9
Holders Change %
+4.59%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
77
Reduced
66
Closed
25
Calls
$787K
Puts
$1.54M
Net Calls
-$750K
Net Calls Change
-$1.22M

Top Buyers

Rank Fund Capital Flow
1
Swedbank
Swedbank
Sweden
+$14.4M
2
BlackRock
BlackRock
New York
+$11.6M
3
SI
Scout Investments
Missouri
+$9.35M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$8.74M
5
Millennium Management
Millennium Management
New York
+$6.85M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$38.2M
2
UBS AM
UBS AM
Illinois
-$34.7M
3
VNIM
Vaughan Nelson Investment Management
Texas
-$28.4M
4
RSCM
Rock Springs Capital Management
Maryland
-$20.2M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Baillie Gifford & Co
176
Baillie Gifford & Co
United Kingdom
$26K +$1.77K +104 +6%
PCM
177
Penserra Capital Management
California
$24K – – –
APA
178
American Portfolios Advisors
New York
$23K +$26.8K +1,576 New
AF
179
Advisornet Financial
Minnesota
$15K – – –
FCB
180
First Command Bank
Texas
$15K – – –
FCFS
181
First Command Financial Services
Texas
$15K – – –
EIP
182
Ellis Investment Partners
Pennsylvania
$10K – – –
SWA
183
Sutton Wealth Advisors
Florida
$9.53K +$1.87K +110 +20%
OCM
184
Orion Capital Management
California
$9K – – –
FHA
185
First Horizon Advisors
Tennessee
$7K -$713 -42 -8%
Osaic Holdings
186
Osaic Holdings
Arizona
$6K +$4.01K +236 +116%
Rockefeller Capital Management
187
Rockefeller Capital Management
New York
$6K +$7.49K +441 New
JCM
188
Jacobi Capital Management
Pennsylvania
$3K – – –
OSAM
189
O'Shaughnessy Asset Management
Connecticut
$3K – – –
CAPTRUST Financial Advisors
190
CAPTRUST Financial Advisors
North Carolina
$3K +$1.66K +98 +78%
EVM
191
Eaton Vance Management
Massachusetts
$3K +$2.92K +172 New
Federated Hermes
192
Federated Hermes
Pennsylvania
$2K -$847K -49,905 -100%
Daiwa Securities Group
193
Daiwa Securities Group
Japan
$2K – – –
PFBT
194
Parkside Financial Bank & Trust
Missouri
$2K – – –
TWA
195
TCI Wealth Advisors
Arizona
$2K +$1.99K +117 New
SFS
196
Sowell Financial Services
Arkansas
$1K -$20.3K -1,193 -94%
HGWM
197
Harvest Group Wealth Management
Massachusetts
$1K +$679 +40 New
Toronto Dominion Bank
198
Toronto Dominion Bank
Ontario, Canada
$1K +$1.02K +60 New
FPS
199
Fieldpoint Private Securities
Connecticut
$1K +$1.1K +65 New
S
200
SignatureFD
Georgia
$1K +$1.36K +80 New
6 7
8
9 10

CHRS Hedge Fund Activity: Q1 2021 in Review

205 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2021, worth a combined $1.17B — down 22% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CHRS positions and 25 closed out — a net gain of 10 holders — while 77 added to existing stakes and 66 trimmed.

The largest buyer was Swedbank, opening a new position worth an estimated $14.4M. The largest seller was Camber Capital Management, exiting entirely with an estimated $38.2M sold.

  • 205 institutional investors held Coherus Oncology (CHRS) as of Q1 2021, up from 196 in Q4 2020.
  • Funds reported $1.17B of Coherus Oncology stock for Q1 2021, down 22% quarter-over-quarter.
  • 35 funds opened new Coherus Oncology positions in Q1 2021 and 25 closed out, a net change of +10 holders.
  • The largest Coherus Oncology buyer in Q1 2021 was Swedbank, an estimated $14.4M added.
  • The largest Coherus Oncology seller in Q1 2021 was Camber Capital Management, an estimated $38.2M sold.

Based on aggregated 13F filings for Q1 2021.